Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis-like disease in a nonhuman primate.
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
Drug reprofiling using zebrafish identifies novel compounds with potential pro-myelination effects.
L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.
CSF Metabolite Analysis May Offer Sensitive Biomarkers for MS
Biogen Idec and Genentech announce restructuring of anti-CD20 collaboration agreement
Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients.
Equivalent Gene Expression Profiles between Glatopa™ and Copaxone®.
Episode 57 with Dr. Timothy Vollmer, on the early phase 3 ocrelizumab results and implications
Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells.
Episode 60 with Dr. Timothy Vollmer on early, highly effective treatment
Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
Petite but Potent
Safety Study of Combination Therapy with Intramuscular Avonex and Oral CellCept in Patients with Multiple Sclerosis
An ADIOL-ERβ-CtBP transrepression pathway negatively regulates microglia-mediated inflammation.
An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.
Teriflunomide for multiple sclerosis.
American Society for Neurochemistry 47th Annual Meeting
Demyelination and Remyelination: From Mechanism to Therapy
MS Research Roundup: July 17, 2014
ACTRIMS-ECTRIMS 2014 -- Day 2, morning
Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.
Autoimmune tolerance eliminates relapses but fails to halt progression in a model of multiple sclerosis.
MS Patient, Ph.D.: Can We Separate Anxiety and Gender in MS?
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

Pages